Jan C. Fagerberg

Nessuna posizione attualmente

62 anni

Health Technology

Consumer Services

Precedenti posizioni note di Jan C. Fagerberg

Società	Posizione	Inizio	Fine
RESPONSE GENETICS, INC	Direttore/Membro del Consiglio	19/07/2010	12/10/2011
RESPONSE GENETICS, INC	Independent Dir/Board Member	16/07/2010	12/10/2011
TOPOTARGET A/S	Direttore Tecnico/Scientifico/R&S	01/01/2009	01/01/2009
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.	Direttore Tecnico/Scientifico/R&S	19/11/2009	-

Karolinska Institutet

Doctorate Degree

Distribuzione geografica

Posizioni

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
RESPONSE GENETICS, INC	Health Technology

Aziende private	2
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.	Health Technology
Topotarget A/S Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark.	Health Technology

Aziende private

Health Technology